KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $3.7 billion.

  • Medtronic's Operating Expenses rose 662.86% to $3.7 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $14.3 billion, marking a year-over-year increase of 163.63%. This contributed to the annual value of $13.8 billion for FY2025, which is 110.24% up from last year.
  • Medtronic's Operating Expenses amounted to $3.7 billion in Q4 2025, which was up 662.86% from $3.6 billion recorded in Q3 2025.
  • In the past 5 years, Medtronic's Operating Expenses ranged from a high of $3.7 billion in Q2 2024 and a low of $3.2 billion during Q1 2021
  • Moreover, its 5-year median value for Operating Expenses was $3.4 billion (2023), whereas its average is $3.4 billion.
  • In the last 5 years, Medtronic's Operating Expenses skyrocketed by 717.08% in 2023 and then plummeted by 596.26% in 2025.
  • Over the past 5 years, Medtronic's Operating Expenses (Quarter) stood at $3.3 billion in 2021, then rose by 2.64% to $3.4 billion in 2022, then increased by 2.57% to $3.5 billion in 2023, then rose by 0.72% to $3.5 billion in 2024, then increased by 6.63% to $3.7 billion in 2025.
  • Its Operating Expenses was $3.7 billion in Q4 2025, compared to $3.6 billion in Q3 2025 and $3.5 billion in Q2 2025.